维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

9篇 您的检索式：作者名="POOJA T"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	Emodin suppresses Wnt signaling in hu- man colorectal cancer cells SW480 and SW620显示文摘	Pooja T Karunagaran D	2014	Eur J Pharmacol2014，14，2：	1
	2	Emodin suppresses Wnt signaling in human eoloreetal cancer cells SW480 and SW6201显示文摘	Pooja T Karunagaran D	2014	Eur J Pharmaeol2014，742，：	1
	3	Structural and electronic properties of CuSbS2 and CuBiS2: Potential absorber materials for thin-film solar cells显示文摘	Jesse T R Aron W Pooja M P	2012	Physical Chemistry Chemical Physics2012，14，20：	1
	4	Emodin suppresses Wnt signaling in human colorectal cancer cells SW480 and SW620 显示文摘	Pooja T Karunagaran D	2014	Eur J Pharmacol2014，742，11：	1
	5	Functionalized goldnanoparticles and their biomedical applications显示文摘	Pooja M T Komal V Vida A D	2011	Nanomaterials2011，1，：	1
	6	Emodin suppresses Wnt signaling in humancolorectal cancer cells SW480 and SW620显示文摘	POOJA T KARUNAGARAN D	2014	Eur J Pharmacol2014，742，：	1
	7	Carbapenemase- producing Klebsiella pneumoniae in Brooklyn,NY:molecular epidemiology and in vitro activity of polymyxin B and other agents 显示文摘	SIMONA B POOJA T USHA K	2005	J Antimicrob Chemother2005，56，1：	1
	8	Emodin suppresses Wnt signaling in human colorectal cancer cells SW480 and SW620显示文摘	Pooja T Karunagaran D	2014	Eur J Pharmacol2014，742，：	1
	9	Surgical route and pathological risk factors in early cervical cancer-Node Zero(SURPEC-N0)显示文摘Aim:The aim of this study is to compare disease-free survival(DFS)and overall survival(OS)in patients with stage I cervical cancer(≤4cms,lymph node-negative)undergoing open radical hysterectomy(ORH)vs.minimally invasive radical hysterectomy(MIRH).Methods:All patients undergoing radical hysterectomy between January 2012-December 2018 from the largest tertiary referral cancer centre were included.A 1:1 propensity matching was done based on four independent prognostic factors to compare DFS and OS with the route of surgery.Results:One hundred and ninety-nine patients were included during the study period.The median age of the cohort was 50 years.The median follow-up of patients was 47 months.Following 1:1 propensity matching,a total of 174 patients were analysed for DFS and OS in ORH(n=87)and MIRH(n=87)groups.Protective measure was used in two-thirds of the patients during MIRH.Twenty-nine patients(16.7%)had recurrences.For the matched cohort(n=174),the DFS at 36 and 60 months was 84.8%(78.1%-89.6%)and 81%(73.4%-86.6%)respectively and the OS was 96.5%(91.7%-98.5%)and 95.6%(90.3%-98%)respectively.There was no statistically significant difference in DFS or OS between ORH and MIRH.Conclusion:The present study showed no difference in oncological outcomes in MIRH compared to ORH.Retrospective audits on patient characteristics such as screening/vaccination history along with surgical technique/load and matching for crucial risk factors should be factored in future studies to eliminate the possible methodological errors.	T S Shylasree Stuti Gupta Akshay Patil Pooja Singh Amita Maheshwari Santosh Menon Supriya Chopra Lavanya Gurram Palak Popat Umesh Mahantshetty Rajendra Kerkar	2022	Journal of Cancer Metastasis and Treatment2022，8，1：	0

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费